<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02942082</url>
  </required_header>
  <id_info>
    <org_study_id>CEBD-CU-2016-10-222</org_study_id>
    <nct_id>NCT02942082</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation for Post Bleaching Hypersensitivity Using Desensitizing Agent During In-office Bleaching</brief_title>
  <official_title>Clinical Evaluation for Post Bleaching Hypersensitivity Using Desensitizing Agent Before and /or After In-office Bleaching</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluating the effect of a desensitizing agent on post-bleaching hypersensitivity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized clinical trail will be done to evaluate the effect of a desensitizing agent ACP
      oral care gel in comparison to a control group on hypersensitivity after bleaching using a
      visual analogue scale.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-bleaching hypersensitivity assessed using visual analogue scale</measure>
    <time_frame>one month</time_frame>
    <description>using visual analogue scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tooth color assessed using value-ordered VITA® Classical Shade Guide</measure>
    <time_frame>one month</time_frame>
    <description>value-ordered VITA® Classical Shade Guide</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Tooth Bleaching</condition>
  <arm_group>
    <arm_group_label>ACP oral care geldesensitizing agent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a desensitizing agent will be applied on tooth before and /or after bleaching.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>glycrin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>glycrin will be applied on tooth before and /or after bleaching.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ACP oral care gel</intervention_name>
    <description>a desensitizing agent will be applied on tooth before and/or after bleaching</description>
    <arm_group_label>ACP oral care geldesensitizing agent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>glycrin</intervention_name>
    <description>glycrin will be applied on tooth surface before and/or after bleaching</description>
    <arm_group_label>glycrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must show no signs of spontaneous dental pain.

          -  Male or female patients between the ages of 18 to 40.

          -  Patients with good general and oral health.

          -  Patients having six caries-free maxillaryanterior teeth without restorations on the
             labial surfaces.

          -  Patients should have central incisors determined to be shade C2 or darker

        Exclusion Criteria:

          -  Patient with spontaneous dental pain.

          -  Patient with anterior restorations or non carious cervical lesion.

          -  Patient having severe internal tooth discoloration (tetracycline stains, fluorosis,
             pulpless teeth), and bruxism habits.

          -  Tempro-mandibular joint problems involving symptomatic pain.

          -  Patients taking analgesics that could alter their normal pain perception level.

          -  Pregnant or breast feeding women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2016</study_first_submitted>
  <study_first_submitted_qc>October 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2016</study_first_posted>
  <last_update_submitted>October 20, 2016</last_update_submitted>
  <last_update_submitted_qc>October 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Silvia Sabry</investigator_full_name>
    <investigator_title>researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

